In-depth investigation revealed that impaired NK cell function in MDS patients may be associated with epigenetic modifications such as aberrant JAK/STAT signaling and DNA methylation, revealing the molecular mechanism of NK cell dysfunction in MDS (35). This evidence concerns the gene SOAT1 and myelodysplastic syndrome.